When international manufacturers start evaluating Brazil, the conversation tends to go in a very predictable direction.
“Who’s the right distributor?”
It’s usually one of the first questions.
And it makes sense.
Brazil’s a large country. Complex geography. Diverse healthcare system.
So naturally, the instinct’s to solve for distribution early.
Find a strong partner. Ensure national coverage. Move forward.
But after working with companies entering Brazil for years, we’ve seen something that challenges that assumption.
In most cases, distribution isn’t the real problem.
Market access is.
The Logic That Feels Right But Isn’t Enough
The typical approach looks something like this:
Get regulatory approval → appoint a distributor → start selling.
On paper, it works.
In practice, something often doesn’t click.
Products are available. Stock’s in place. The distributor’s active.
And yet, adoption’s slower than expected.
Hospitals take time to incorporate the product. Demand builds gradually or sometimes not at all.
At that point, the question shifts.
“Is the distributor underperforming?”
Sometimes that’s true.
But often, the issue sits somewhere else.
Distribution Delivers Products. Market Access Creates Demand.
There’s an important distinction here.
Distribution’s about logistics and reach.
Getting the product into the country. Moving it across regions. Making it available.
Market access is about something different.
It’s about:
How hospitals evaluate new technologies. How procurement decisions are made. How physicians influence adoption. How products are positioned clinically and economically.
Distribution answers:
Can the product get there?
Market access answers:
Will anyone actually use it?
Why This Gap Matters in Brazil
Brazil’s healthcare system’s not centralized.
Hospitals operate with a high degree of autonomy. Procurement processes vary. Clinical decision making often involves multiple stakeholders.
Which means that simply having a product available doesn’t guarantee adoption.
We’ve seen situations where:
Products were widely distributed but rarely used.
Distributors had strong coverage but limited clinical engagement.
Inventory was available but demand never really took off.
Not because the product lacked value.
But because the market hadn’t been activated.
The Role Distributors Can and Can’t Play
This is where expectations sometimes get misaligned.
Distributors are essential. They play a critical role in navigating the market.
But they’re not always structured to handle every aspect of market access.
Some are excellent at logistics.
Others have strong hospital relationships.
A few combine both with clinical engagement.
But expecting a single partner to fully bridge regulatory, commercial, and clinical dynamics—without a defined strategy can lead to gaps.
And those gaps show up in adoption.
What Successful Companies Tend to Do Differently
Manufacturers who gain traction in Brazil usually approach the market in a more layered way.
They don’t rely on distribution alone to drive growth.
They think about:
How the product will be positioned clinically. Which hospitals are priorities. How physicians will be engaged. What evidence’s needed for adoption. How procurement conversations will unfold.
Distribution becomes one part of a broader strategy.
Not the strategy itself.
Market Access Starts Earlier Than Most Think
One of the most important shifts we see in successful market entries’s timing.
Companies that wait until after regulatory approval to think about market access often lose momentum.
Those who start earlier sometimes well before approval tend to move faster once the product’s cleared.
Because the groundwork’s already in place.
Relationships are established. Conversations have started. The market’s more prepared.
By the time the product’s available, adoption doesn’t need to start from zero.
A Different Way to Approach Brazil
Instead of asking:
“Who should distribute our product?”
A more effective question might be:
“How will our product be adopted inside hospitals and what needs to happen to get there?”
That shift changes everything.
It expands the conversation beyond logistics.
And brings focus to the elements that actually drive growth.
Brazil Rewards Those Who Connect the Dots
Brazil’s not an easy market.
But it’s also not an unpredictable one.
When regulatory strategy, distribution, and market access are aligned, things tend to move.
Adoption becomes more consistent. Growth becomes more sustainable.
When they’re not, companies often find themselves trying to fix the structure after the fact.
And that’s where time—and opportunity—is lost.
It’s Not About Distribution Alone
Distribution matters. A lot.
But on its own, it rarely solves the full challenge.
Because in Brazil, success isn’t just about getting products into the country.
It’s about getting them into the hands of physicians and into the routine of hospitals.
And that requires more than reach.
It requires access.
Find out more about BPO in RA! 
*Budget for registration ownership transfer, Market Access Strategy, and BPO in RA services for your company: www.brisa.com.br 
